Gemin X is developing novel targeted therapies, including those that modulate apoptosis, to improve outcomes and quality of life for patients with cancer

Patients & Clinicians

Gemin X has multiple ongoing and planned clinical trials of its drug candidates across a broad range of cancer types as both a single agent and combination therapy.
>>more

Our Products

Gemin X is developing small molecules that target specialized pathways for cancer, including key regulators in the genesis and progression of cancer.
>>more